RxDoctor Payments DataLook up a doctor →

IQIRVO: payments to doctors

Payments that named IQIRVO as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$4.2M
Providers
8,152
Transactions
25,118
Average per transaction
$168

The per-transaction average — $168 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 8,152 providers the average total is $519, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Ipsen Biopharmaceuticals, Inc$4,139,30797.9%
Ipsen Innovation$83,3722.0%
Albireo Pharma, Inc.$3,8120.1%
Ipsen Pharma SAS$1,7620.0%
← All drugs & devices